A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis
R. D. Hull, G. E. Raskob, J. Hirsh and D. L. Sackett
Recent data from randomized trials have provided a clear understanding of
the effectiveness and safety of differing long-term anticoagulant therapies
for proximal vein thrombosis. An issue that has not been addressed is their
cost-effectiveness. We have performed a cost-effectiveness analysis to rank
alternative approaches for long-term therapy. Less intense oral
anticoagulant therapy using warfarin sodium is the most cost-effective
approach and is preferred in the majority of patients.
